arrow
G

Gina Ferrazzano

Department of Human Neurosciences
H指数:26
被引数:1,914

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty

真实世界中奥法鲁单抗治疗复发型多发性硬化24个月的效果:疗效、安全性及虚弱症的影响

2025-09-190
OAAI
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study

从 fingolimod 切换到 siponimod 的安全性评估:一项意大利多中心前瞻性研究

2025-07-010
PRE
Phenotypic comparison between combined dystonia-parkinsonism and idiopathic adult-onset dystonia

联合肌张力障碍-帕金森综合征与特发性成人起病肌张力障碍的表型比较

2025-04-170
PRE
Does sex influence the natural history of idiopathic adult-onset dystonia?
2024-03-012
OA
Does thyroid diseases contribute to the natural history of idiopathic adult-onset dystonia? Data from the Italian Dystonia Registry
2024-02-201
PRE
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients

克拉屈滨和ocrelizumab在复发缓解型多发性硬化症患者外周血单核细胞中诱导差异miRNA谱

2023-12-133
OAAI
Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEG

多发性硬化症中运动乏力的神经基础: 使用神经肌肉评估和tms-eeg的多模式方法

2023-05-019
OAAI
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?
2022-08-163
OAAI